Literature DB >> 24342415

Successful treatment of a patient with symptomatic long QT syndrome type 3 using ranolazine combined with a beta-blocker.

Maarten P van den Berg1, Freek van den Heuvel2, J Peter van Tintelen3, Paul G A Volders4, Isabelle C van Gelder5.   

Abstract

Entities:  

Keywords:  Beta-blocker; Late inward sodium current; Long QT syndrome type 3; N1325S; Ranolazine; SCN5a

Mesh：

Substances：

Year:  2013        PMID： 24342415     DOI： 10.1016/j.ijcard.2013.11.066

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3.

Authors:  Reina Bianca Tan; Sujata Chakravarti; Melissa Busovsky-McNeal; Abigail Walsh; Frank Cecchin
Journal:  HeartRhythm Case Rep       Date:  2016-10-17

2.  Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm.

Authors:  Panagiotis Margos; Nikolaos Margos; Nadiya Mokadem; Ilias Patsiotis; Athanasios Kranidis
Journal:  Clin Case Rep       Date:  2017-06-02

Review 3.  Impact of ranolazine on ventricular arrhythmias - A systematic review.

Authors:  George Bazoukis; Gary Tse; Konstantinos P Letsas; Costas Thomopoulos; Katerina K Naka; Panagiotis Korantzopoulos; Xenophon Bazoukis; Paschalia Michelongona; Stamatis S Papadatos; Konstantinos Vlachos; Tong Liu; Michael Efremidis; Adrian Baranchuk; Stavros Stavrakis; Costas Tsioufis
Journal:  J Arrhythm       Date:  2018-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.